TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 42 filers reported holding TRINITY BIOTECH PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 239 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 239 | -53.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 509 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 509 | +88.5% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -50.0% | 270 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 270 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |